Search Results for 'rivaroxaban bleeding'

rivaroxaban bleeding published presentations and documents on DocSlides.

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Rivaroxaban compared with enoxaparin for the prevention of
Rivaroxaban compared with enoxaparin for the prevention of
by luanne-stotts
Alexander T Cohen . On behalf of the MAGELLAN Ste...
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
Stroke, Bleeding, and
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Thromboembolic protocols
Thromboembolic protocols
by cecilia
& safe anticoagulant prescribing. July 2020. D...
Review on NOACs Studies Dr.
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Reversing Course:  Managing Anticoagulation and Antiplatelet Bleeding
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
by kyle585
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
MAGELLAN Primary efficacy endpoint  at 10 days (DVT, symptomatic PE,
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
by HoneyBun
VTE death. ) for . rivaroxaban. vs. . enoxaparin....
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...
Rivaroxaban in stable peripheral or carotid artery disease
Rivaroxaban in stable peripheral or carotid artery disease
by basidell
Sonia Anand, on . behalf of the COMPASS Steering C...
Dr. Phil Wells  on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
Novel Oral Anticoagulants
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Bleeding  and cancer risk in patients with vascular
Bleeding and cancer risk in patients with vascular
by danika-pritchard
Bleeding and cancer risk in patients with vascul...
Alexander G
Alexander G
by min-jolicoeur
G. . Turpie. Professor Emeritus of Medicine. McM...
New Oral Anticoagulants: A    Review
New Oral Anticoagulants: A Review
by phoebe-click
Babak Moini, MD. Veterans Affairs Hospital. Noon ...
The Novel Oral Anticoagulants
The Novel Oral Anticoagulants
by tatyana-admore
Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...
Update in the Perioperative and Emergency Management of Nov
Update in the Perioperative and Emergency Management of Nov
by danika-pritchard
Annelise Gallien, MD FRCPC. Moncton City Hospital...
Update on the New Oral Anticoagulants
Update on the New Oral Anticoagulants
by sherrill-nordquist
Eliot Williams, MD PhD. Division of Hematology &a...
Management of
Management of
by marina-yarberry
Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...
Oral anticoagulants in the 21
Oral anticoagulants in the 21
by natalia-silvester
st. century: A practical guide to using newer A...
Dodson Thompson, DO
Dodson Thompson, DO
by lois-ondreau
Northlakes. Community Clinic. Minong, WI. Novel ...
POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF
POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF
by phoebe-click
NOACS IN AF. Where Do We Stand With NOACs in AF ...
The thick and thin of it: Reviewing Anticoagulant Options
The thick and thin of it: Reviewing Anticoagulant Options
by oneill
Lanae Fox, . PharmD. , BCPS. I have no financial d...
Spotlight  Case New Oral Anticoagulants
Spotlight Case New Oral Anticoagulants
by skylar
This presentation is based on the . December 2013....
New (Direct)Oral  anti-coagulants in the treatment of VTE
New (Direct)Oral anti-coagulants in the treatment of VTE
by ariel
Dr NA Smith - Haematology Dept. Heart of England...
Atrial  Fibrilation (Anticoagulation)
Atrial Fibrilation (Anticoagulation)
by CupcakeCutie
M.A . Akbarzadeh. MD. Assistant . professor of . ...
DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag
DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag
by cecilia
Steven Johnston, BDS, MSc, MFDS RCS(Ed), Dental Of...
COMPASS: Show Us the Way for Medical Management of PAD
COMPASS: Show Us the Way for Medical Management of PAD
by miller
Clinical Associate Professor of Medicine. SSM Heal...
Anisah Ahmad Pharmacist
Anisah Ahmad Pharmacist
by genevieve
01904 72(4328). Anticoagulants . Warfarin . Novel ...